Calidi Biotherapeutics Inc (CLDI)
0.2304
-0.01
(-4.79%)
USD |
NYAM |
May 17, 16:00
0.2304
0.00 (0.00%)
After-Hours: 16:40
Calidi Biotherapeutics Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -21.80M |
| September 30, 2022 | -9.338M |
| Date | Value |
|---|---|
| September 30, 2021 | -5.029M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.80M
Minimum
Sep 2023
-5.029M
Maximum
Sep 2021
-12.05M
Average
-9.338M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| Minerva Neurosciences Inc | -6.094M |
| Viking Therapeutics Inc | -6.134M |
| CytomX Therapeutics Inc | -26.04M |
| Genprex Inc | -4.964M |
| Janux Therapeutics Inc | -14.84M |